Skip to search formSkip to main contentSkip to account menu

extensive stage small cell lung cancer

Known as: lung cancer, extensive stage small cell, Small Cell Lung Cancer, Extensive Stage, Extensive Stage Small Cell Lung Carcinoma 
Small cell lung carcinoma which has spread beyond one hemi-thorax and the regional lymph nodes.
National Institutes of Health

Related topics

Related topics

23 relations
BronchiChestEndocrine systemEpithelial Cells

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer.
PURPOSE To investigate the correlation among p300, CBP and MLL expression and the clinicopathological characteristics in resected… 
2004
2004
Carboplatin in Combination with Bendamustine in Previously Untreated Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)
AbstractBackground and objective: Bendamustine is an alkylating agent with high efficacy in non-Hodgkin’s lymphoma and multiple… 
Highly Cited
2001
Highly Cited
2001
A targeted cytotoxic somatostatin (SST) analogue, AN-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice.
2001
2001
Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: a phase II trial of the Southwest Oncology Group.
PURPOSE This study was designed to determine the efficacy and toxicity of cisplatin, etoposide, and paclitaxel (PET) in patients… 
Review
2001
Review
2001
Chemotherapy as treatment of primary and recurrent small cell lung cancer.
1996
1996
CYP2D6 genotypes in Spanish women with breast cancer.
1993
1993
The Impact of Dose Intensity of Standard Chemotherapy Regimens in Extensive Stage Small Cell Lung Cancer
Oncologists often attenuate the doses of chemotherapy drugs in published standard regimens to avoid toxicity. The impact on… 
1992
1992
CODE chemotherapy with or without recombinant human granulocyte colony-stimulating factor in extensive-stage small cell lung cancer.
CODE therapy demonstrated high antitumor activity in extensive-stage small cell lung cancer (SCLC). Toxicity was acceptable in a… 
1987
1987
Endourologic "Sandwich" Therapy for Extensive Staghorn Calculi
We present our experience with an endourologic "sandwich" protocol for treating patients with extensive staghorn calculi. The… 
1967
1967
The nature and toxicity of the photoconversion products of aldrin
As part of the studies concerning the environmental fate of pesticides, the nature and toxicity of the products obtained when… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)